Recro Pharma, Inc. 4
4 · Recro Pharma, Inc. · Filed Feb 18, 2016
Insider Transaction Report
Form 4
Graff Fred
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2016-02-16+91,000→ 91,000 totalExercise: $6.10Exp: 2026-02-16→ Common Stock (91,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. The stock option is an inducement grant under NASDAQ listing rule 5635(c)(4).